Column Group III-A, LP

10% OwnerTenaya Therapeutics, Inc. (TNYA) · full profile →Form 4 · filed Feb 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$503K
Net Open-Market Flow
-$503K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 23, 2026Sell(S)162K$0.60$97K2.2M
Feb 23, 2026Sell(S)144K$0.60$86K2.0M
Feb 20, 2026Sell(S)278K$0.61$169K2.4M
Feb 20, 2026Sell(S)246K$0.61$150K2.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-067007) within minutes of acceptance. Every field above traces to the original document. Verify it directly: